Therapeutic molecules and deviates for CRC
US10058582B2 · kind B2 · utility
0Cited by
0References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 12, 2016 |
| Grant date | Aug 28, 2018 |
| Priority date | — |
| Expiry date | Aug 12, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The chemically synthesized compound Tricin 7-O-beta-D-glucopyranoside, native to the plant Deschampsia Antarctica and present in aqueous extracts of the plant Deschampsia Antarctica said compound having the ability to inhibit tumor growth in mammals with colorectal carcinoma.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.